Modern Science Meets Cannabis-Based Medicine
XPhyto Therapeutics is a science-based cannabis company focusing on medical formulation, clinical validation, and emerging European markets. In fact, …
XPhyto Therapeutics is closing the gap between traditional cannabis-based medicine and modern scientific approaches
XPhyto Therapeutics is a science-based cannabis company focusing on medical formulation, clinical validation, and emerging European markets. In fact, the company has a 100% owned German subsidiary, Bunker Pflanzenextrakte GmbH. They've been granted a unique German cannabis cultivation and extraction licence for scientific purposes. This was issued by the German Federal Institute for Drugs and Medical Devices (BfArM).
Additionally, XPhyto Laboratories Inc., is a wholly owned subsidiary of XPhyto Therapeutics Corp. In general, they provide certified third party analytical testing (cannabinoids, heavy metals, pesticides, etc.) to Canadian licenced growers, processors, dispensaries, and government agencies.
More on XPhyto Therapeutics
Moreover, XPhyto is pursuing other opportunities in Germany. These include cultivation, processing, manufacturing, import, and distribution. Furthermore, in Canada, two exclusive 5-year engagements with the Faculty of Pharmacy at a major Canadian university provide certified extraction, isolation, and formulation facilities, drug research and development expertise, as well as commercial analytical testing capability.
"The long term vision for XPhyto is to build one of the largest distribution networks in Germany for medical and CBD products", says CEO and Director, Hugh Rogers.
For more information on XPhyto Therapeutics Corp. (XPHY:CSE) please fill out the form below.
Latest Articles
Hot Companies
You might also like
BTV Showcases Contango Ore, Critical Elements Lithium, Dryden Gold, FireFox Gold, Kirkland Lake, Klondike Gold, and Selkirk Mines
This week, BTV - Business Television we feature growth-focused mining companies advancing major projects across North America and Europe. From emerging producers and strategic combinations to high-grade exploration and critical mineral development, this episode highlights the next wave of opportunity in the resource sector, including:
Selkirk Copper: A Yukon restart positioned to deliver new Canadian copper supply by 2028
A 50,000-metre drill program began last summer to expand understanding of the resource and guide updated mine design. The goal is to define a 12–15 year mine life while refreshing permits and engineering.
